# A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

> **NCT04450498** · PHASE4 · COMPLETED · sponsor: **Walvax Biotechnology Co., Ltd.** · enrollment: 260 (actual)

## Conditions studied

- Neisseria Meningitides Meningitis

## Interventions

- **BIOLOGICAL:** Yuxi Walvax MPV ACYW® vaccine
- **BIOLOGICAL:** Sanofi Pasteur Menactra® vaccine

## Key facts

- **NCT ID:** NCT04450498
- **Lead sponsor:** Walvax Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-23
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04450498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04450498, "A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04450498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*